MEDIUM confidence: 100% data completeness, but the composite (55) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.9B— | $3.3B+13.0% | $3.1B-4.5% | $3.6B+16.1% | $3.8B+6.6% |
| EPS (dil.) | $2.18— | $3.00+37.6% | $2.60-13.3% | $4.02+54.6% | $3.00-25.4% |
| Free Cash Flow | $1.5B— | $1.2B-16.4% | $913M-24.8% | $1.3B+39.6% | $1.5B+14.9% |
| Gross Margin | 69.6% | 69.1%-0.5pp | 75.4%+6.2pp | 77.2%+1.8pp | 68.5%-8.7pp |
| Operating Margin | 46.4% | 48.8%+2.4pp | 44.4%-4.4pp | 54.7%+10.3pp | 41.3%-13.4pp |
| Net Margin | 31.8% | 37.4%+5.6pp | 32.9%-4.5pp | 43.6%+10.7pp | 30.4%-13.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $48 avg across 5 analysts.
Buy-rated share 27% → 29% over ~3 months (+2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.91 | $0.99 | +9.2% |
| May 2026 | $0.74 | $0.85 | +14.6% |
| Feb 2026 | $0.84 | $0.47 | -44.4% |
| Nov 2025 | $0.88 | $0.87 | -1.1% |
| Aug 2025 | $0.83 | $0.87 | +4.9% |
| May 2025 | $0.83 | $0.79 | -5.2% |
| Feb 2025 | $0.85 | $0.85 | +0.1% |
| Nov 2024 | $0.83 | $0.74 | -10.8% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 1.7%/yr (revenue basis).
Base free cash flow $1.2B (avg FY2023–FY2025; latest year $1.5B) · equity value $20.0B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider $300K over 180 days (2 open-market buys, 0 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 55 for WES indicates a neutral outlook, driven by strong profitability and momentum scores, which are offset by lower value and growth scores. The stock's high ROE of 34.1% and operating margin of 39.7% contribute to its strong profitability, while a 27.2% return over the past year exhibits strong momentum. In contrast, the stock trades at a P/E of 15.1 and EV/EBITDA of 12.6, which is relatively in line with peers, but revenue growth of 6.6% and EPS growth of -25.5% weigh on its growth score.